Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Askevold, Erik Tandberg; Nymo, Ståle; Ueland, Thor; Gravning, Jørgen; Wergeland, Ragnhild; Kjekshus, John; Yndestad, Arne; Cleland, John G F; McMurray, John J V; Aukrust, Pål; Gullestad, Lars

Askevold, Erik Tandberg; Nymo, Ståle; Ueland, Thor; Gravning, Jørgen; Wergeland, Ragnhild; Kjekshus, John; Yndestad, Arne; Cleland, John G F; McMurray, John J V; Aukrust, Pål; Gullestad, Lars.

Affiliation

Askevold ET; Department of Cardiology, University of Oslo, Oslo, Norway. erik.tandberg.askevold@rr-research.no

Circ Heart Fail ; 6(1): 91-8, 2013 Jan.

Article in En | MEDLINE | ID: mdl-23230311

Subject(s)

Cytokine Receptor gp130/blood; Fluorobenzenes/therapeutic use; Heart Failure/blood; Pyrimidines/therapeutic use; Sulfonamides/therapeutic use; Aged; Biomarkers/blood; Female; Follow-Up Studies; Heart Failure/drug therapy; Heart Failure/mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Interleukin-6/blood; Male; Middle Aged; Prognosis; Retrospective Studies; Rosuvastatin Calcium; Survival Rate/trends

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Cytokine Receptor gp130 / Fluorobenzenes / Heart Failure Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Circ Heart Fail Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2013 Type: Article Affiliation country: Norway

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google